Think20 Labs and cannabisMD Partner to Ensure Safety of CBD Products

• Think20 Labs uses technology that has been applied to the Mars Rovers and the National Cancer Institute.
• CannabisMD’s CEO believes that the lack of correct information leads to confusion in the CBD market.

The CBD industry is thriving right now, as more and more companies come out with products that could satisfy the needs of consumers. However, all products are not created with the same care and effort, which is why testing is crucial for safety and quality. With so many counterfeit products in the food and drug industries, it should come as no surprise that CBD can be a victim to this problem as well.

In an effort to ensure that legitimate products are brought to the market, a non-advocacy consumer education platform named cannabisMD has partnered with Think20 Labs, which is a lab testing company. In this new collaboration, the two companies aim to make sure that the CBD products entered in the market have no contamination and are safe for customers. Think20’s state-of-the-art facilities allow for the collaboration to use the same technology as what the Mars Rover and the National Cancer Institute use.

Michael Klein, the CEO of cannabisMD, spoke with Benzinga, saying,

“There’s so much clutter and confusion about CBD. Misinformation and products that make claims that are untrue or contain everything from mold to E. coli only adds to this confusion and generate fear. CannabisMD cuts through the clutter and navigates consumers though a journey of discovery of potential benefits of CBD for their health and wellness.”

Klein states that Think20 Labs shares their goal, aiming to improve the safety of customers. The processes in the lab and technology is “far superior” to anything that cannabisMD has seen.

By offering blind testing, Klein explains,

“We are empowering consumers with greater detail and understanding of what really is in the bottle and surface quality brands. This collocation has created the world’s safest marketplace.”